ASSEMBLY BIOSCIENCES, INC. 8-K

What Happened
Assembly Biosciences, Inc. (ASMB) filed a Form 8-K on March 19, 2026 to announce its financial results for the quarter and the full year ended December 31, 2025. The company issued a press release reporting those results, and that press release is attached to the 8-K.

Key Details

• The announcement was made via press release dated March 19, 2026, covering the quarter and year ended December 31, 2025.
• The press release is furnished as Exhibit 99.1 to the Form 8-K.
• The filing also includes the Cover Page Interactive Data File (Inline XBRL) as Exhibit 104.
• The 8-K was signed by John O. Gunderson, VP, General Counsel and Corporate Secretary, on March 19, 2026.

Why It Matters
This 8-K formally notifies investors that Assembly has reported its latest quarterly and full-year financial performance. Investors should read the attached press release (Exhibit 99.1) for reported revenue, earnings (or loss), cash position and any management commentary or forward-looking statements, since those figures and disclosures are the material items that can affect investment decisions.